Searched for
MOREPEN EARNINGS
Here's why Mayuresh Joshi is bullish on Morepen LabsSo, to that extent, there is some element of stickiness that comes through in numbers. But one must also understand both in terms of their ...
Mayuresh Joshi on his 2 top bets in pharma & what he likes in oil & gas sectorMayuresh Joshi from Marketsmith India shared insights on favored pharma stocks like Natco, Morepen, Cipla, and Dr Reddy's, emphasizing stro...
Mid and smallcap stocks rebound sharply; was a bear attack just a 1-day show?Mazagon Dock Shipbuilders, JSW Energy, NHPC, Coromandel International, Oil India, Indian Railway Finance Corporation, and Sona BLW Precisio...
Stocks of these 21 cos tumble over 20% in 1 year as profits slump for 4 straight quartersAt least 21 Indian companies with a market cap of over INR 5bn ($66m) saw their profits decline in each of the past four quarters and their...
Market Movers: Investors dump Nykaa shares ahead of earningsNykaa has faced massive selloff off late as Street dumped shares of richly valued new-age companies against the backdrop of Fed rate hikes,...
Morepen Laboratories Q3 Results: Profit dips 10% to Rs 22 crNet revenue, however, rose to Rs 399.19 crore in the third quarter as compared with Rs 310.26 crore in the same period of 2020-21, Morepen ...
Morepen Labs Q2 results: Net profit up 38% at Rs 37 crore"With massive increase in active pharmaceutical ingredient (API) demand globally and more particularly with frequent supply disruptions fro...
Morepen Laboratories Q1 results: Net profit jumps 57% to Rs 30 crIts net revenue stood at Rs 388.31 crore in the quarter under consideration, up 50 per cent against Rs 258.97 crore a year ago, Morepen Lab...
125% jump in a month, 360% in a year; safety rush turns this laggard a multibaggerThe smallcap pharma scrip has been thumping rock and roll over the past few weeks.
Morepen Laboratories posts two-fold jump in Q4 profitThe drug firm's consolidated net profit came in at Rs 26.76 crore for the quarter ended March 31.
Stocks in news: Reliance Inds, Hindustan Unilever, Titan, Bajaj Auto and Ambuja CementsHindustan Unilever, Titan and Bajaj Auto, Ambuja Cements, Motherson Sumi, Bajaj Holdings, Shriram Transport, AU SFB, IndiaMart InterMesh an...
Midcap pharma regains its vigour on Dalal StreetSo far this week, Nectar Life has gained 36 per cent, Morepen has risen 30 per cent, Panacea has moved up 28 per cent Suven Life has advanc...
Morepen Labs Q3 results: Net profit rises over two-fold to Rs 24 crConsolidated total revenue of the company stood at Rs 310.26 crore for the quarter under consideration. It was Rs 234.65 crore for the same...
Stocks in the news: RIL, Vodafone Idea, Asian Paints, Bharti Airtel, BoB and ONGCBerger Paints, Balrampur Chini, Bank of Baroda and Page Industries will unveil their March quarter earnings on Tuesday.
Morepen Labs Q4 results: Net profit rises 5% to Rs 11 croreIts consolidated total revenue stood at Rs 208.38 crore for the quarter under consideration.
Germ theory: How probiotic products are flying off the shelvesProbiotics gain demand in the new millennium but there is still a lot of grey area around the science of ingesting good bacteria.
Stock market update: Market trades higher; Shriram EPC, Biocon surgeThe Sensex rallied over 340 points, and Nifty breached the 11,200 mark for the first time today.
Talking stock: HPCL valuations attractive after the recent correctionIn my view, Greenply doesn’t have solid growth momentum in the last five years.
These stocks plunged up to 15% on NSEIndian equity benchmarks Nifty and Sensex extended the losses for the second session on Wednesday.
Talking stock: Hindalco fairly priced, move to CILEvery week, an expert selected by ET answers queries from our readers on stocks